Comparison of different miR-21 inhibitor chemistries in a cardiac disease model
Thomas Thum(Medizinische Hochschule Hannover), Stefan Engelhardt(Heidelberg University), Johann Bauersachs(Medizinische Hochschule Hannover), Balkrishen Bhat, Nelson Chau, Peter S. Linsley(Rosetta Stone (United States)), Shashi Kumar Gupta(Central Drug Research Institute)
Cited by 109
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
CTLA-4 is a second receptor for the B cell activation antigen B7.
|The Journal of Experimental Medicine|1991|1.7k